ASR UNI FEMORAL IMPL SIZE 49
Report
- Report Number
- 1818910-2013-26489
- Event Type
- Injury
- Date Received
- September 5, 2013
- Date of Event
- August 22, 2013
- Report Date
- December 26, 2013
- Manufacturer
- DEPUY INTL., LTD. - 8010379
- Product Code
- KWA
- PMA / PMN Number
- PK040627
- Removal / Correction Number
- Z-1749/1816-2011
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- SC, US
- Reporter Occupation
- ATTORNEY
Narratives
DEPUY STILL CONSIDERS THIS INVESTIGATION CLOSED.
DEPUY STILL CONSIDERS THIS INVESTIGATION CLOSED.
THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.
LITIGATION PAPERS ALLEGE PHYSICAL INJURY, PAIN, BODILY IMPAIRMENT, DEBILITATING LACK OF MOBILITY, AND ELEVATED METAL ION LEVELS.
UPDATE 12/26/2013 - PLAINTIFF¿S PRELIMINARY DISCLOSURE FORM WAS RECEIVED, WHICH IDENTIFIED DOI AND DOB INFORMATION. PART/LOT WAS IDENTIFIED ON PATIENT STICKER SHEET. THE COMPLAINT AND ASSOCIATED MDRS WERE UPDATED. COMPLAINT WAS UPDATED ON 01/09/2014. COMMENT: THERE IS A DOI DISCREPANCY BETWEEN LITIGATION AND THE PPD. DUE TO ACCURACY, THE DOI FROM THE PPD WILL BE REPORTED. SHOULD WE RECEIVE ADDITIONAL INFORMATION, WE WILL UPDATE IF NEEDED.
(B)(6) 2012 - PATIENT WAS REVISED TO ADDRESS ACETABULAR CUP LOOSENING. (B)(4) 2013 - LITIGATION PAPERS ALLEGE PHYSICAL INJURY, PAIN, BODILY IMPAIRMENT, DEBILITATING LACK OF MOBILITY, AND ELEVATED METAL ION LEVELS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 442047 | ASR UNI FEMORAL IMPL SIZE 49 | FEMORAL HEAD | KWA | DEPUY INTL., LTD. - 8010379 | 2846601 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 57 YR | Other |